Therapeutic options and treatment of muscle invasive bladder cancer.
Carcinoma of the bladder is the second most common genitourinary malignancy. Although several treatments exist, the gold standard therapy for muscle invasive bladder cancer (> or = stage T2) is cystectomy with urinary diversion. We review various surgical treatments for muscle invasive bladder cancer, focusing on the reported survival rates, complications, advantages and disadvantages of each therapeutic modality.
O'Connor
R C
RC
Louis A. Weiss Memorial Hospital, Section of Urology, 5th Floor, 4646 North Marine Drive, Chicago, Illinois 60640, USA. CoreyOC@aol.com
Alsikafi
N F
NF
Steinberg
G D
GD
D017024:Chemotherapy, Adjuvant; D015653:Cystectomy; D006801:Humans; D019042:Muscle Neoplasms / Q000556:secondary*; D020360:Neoadjuvant Therapy; D009361:Neoplasm Invasiveness / Q000473:pathology; D018714:Radiotherapy, Adjuvant; D015996:Survival Rate; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D014547:Urinary Diversion